title: Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement.
abstract: Using proteomic analysis, we identified candidate autoantigens specific for central nervous system (CNS) involvement in systemic lupus erythematosus (SLE). Proteins, extracted from cultured human neuroblastoma cells, were separated both by SDS-PAGE (1-DE) and two-dimensional electrophoresis (2-DE), and transferred to membranes. Western blot analysis was performed using serum samples from 30 SLE patients with CNS involvement (CNS-Lupus) and from 30 SLE patients without CNS involvement (non-CNS-SLE). The detected autoantigens were identified using MALDI-TOF/TOF MS. On the 1-DE Western blot, we detected 32 antigenic bands in the serum samples from the CNS-Lupus patients. Among them, four bands were detected significantly more frequently in the CNS-Lupus patients than in the non-CNS-SLE patients. Three bands were detected in four or more of the CNS-Lupus patients but in only one or none of the non-CNS-SLE patients. We thus selected these seven bands for the next investigations. Next, we detected protein spots corresponding to the selected seven bands by 2-DE Western blot and identified four proteins. They are peroxiredoxin-4, ubiquitin carboxyl-terminal hydrolase isozyme L1, splicing factor arginine/serine-rich 3, and histone H2A type 1. These four candidate autoantigens for the anti-neuronal cell antibodies would be a useful marker for CNS-Lupus.
authors.affiliation: Clinical Proteomics and Molecular Medicine, St Marianna University Graduate School of Medicine, Kawasaki, Kanagawa, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Iizuka
authors.forename: K
authors.initials: K
authors.lastname: Okamoto
authors.forename: R
authors.initials: R
authors.lastname: Matsushita
authors.forename: M
authors.initials: M
authors.lastname: Kimura
authors.forename: K
authors.initials: K
authors.lastname: Nagai
authors.forename: M
authors.initials: M
authors.lastname: Arito
authors.forename: M S
authors.initials: MS
authors.lastname: Kurokawa
authors.forename: K
authors.initials: K
authors.lastname: Masuko
authors.forename: N
authors.initials: N
authors.lastname: Suematsu
authors.forename: S
authors.initials: S
authors.lastname: Hirohata
authors.forename: T
authors.initials: T
authors.lastname: Kato
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001324:Autoantigens / Q000097:blood / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D045744:Cell Line, Tumor; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D006657:Histones / Q000276:immunology; D006801:Humans; D020945:Lupus Vasculitis, Central Nervous System / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009447:Neuroblastoma; D054464:Peroxiredoxins / Q000276:immunology; D016601:RNA-Binding Proteins / Q000276:immunology; D000068103:Serine-Arginine Splicing Factors; D043222:Ubiquitin Thiolesterase / Q000276:immunology; D055815:Young Adult
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D015415:Biomarkers; D006657:Histones; D016601:RNA-Binding Proteins; C491388:SRSF3 protein, human; C482860:UCHL1 protein, human; D000068103:Serine-Arginine Splicing Factors; C515980:PRDX4 protein, human; D054464:Peroxiredoxins; D043222:Ubiquitin Thiolesterase